Plasma-Derived Exosomal microRNA-130a Serves as a Noninvasive Biomarker for Diagnosis and Prognosis of Oral Squamous Cell Carcinoma

Table 2

Performance of exosomal miR-130a for detection of OSCC with different TNM stages.

Group	Healthy control	Stage I + II	Stage III + IV	Stage I	Stage II	Stage III	Stage IV
Healthy control	—	—	—	—	—	—	—
Stage I + II	<0.0001	—	—	—	—	—	—
Stage III + IV	<0.0001	0.009	—	—	—	—	—
Stage I	<0.0001	0.5	0.002	—	—	—	—
Stage II	<0.0001	0.533	0.164	0.262	—	—	—
Stage III	<0.0001	0.015	0.706	0.005	0.133	—	—
Stage IV	<0.0001	0.084	0.687	0.02	0.417	0.501	—

Mean value<0.05.